Evolv Technology Announces Receipt of Extension from Nasdaq Stock Market
Evolv Technology (NASDAQ: EVLV) has received an extension from Nasdaq regarding its compliance with listing requirements. The extension, granted on January 31, 2025, gives the company until May 19, 2025 to file its Q3 2024 Quarterly Report (Form 10-Q). The extension was granted as an exception to Nasdaq's Listing Rule 5250(c)(1), which requires timely filing of periodic financial reports with the SEC.
The company is working with AlixPartners LLP to expedite the filing process and plans to host a public conference call to review financial results once the report is filed.
Evolv Technology (NASDAQ: EVLV) ha ricevuto una proroga da Nasdaq riguardo la sua conformità ai requisiti di quotazione. La proroga, concessa il 31 gennaio 2025, dà all'azienda tempo fino al 19 maggio 2025 per presentare il suo rapporto trimestrale Q3 2024 (Modulo 10-Q). La proroga è stata concessa come eccezione alla Regola di Quotazione 5250(c)(1) di Nasdaq, che richiede la presentazione tempestiva dei rapporti finanziari periodici alla SEC.
L'azienda sta collaborando con AlixPartners LLP per accelerare il processo di deposito e prevede di tenere una conferenza telefonica pubblica per rivedere i risultati finanziari una volta che il rapporto sarà presentato.
Evolv Technology (NASDAQ: EVLV) ha recibido una extensión de Nasdaq respecto a su cumplimiento con los requisitos de cotización. La extensión, otorgada el 31 de enero de 2025, le da a la empresa hasta el 19 de mayo de 2025 para presentar su Informe Trimestral Q3 2024 (Formulario 10-Q). La extensión se concedió como una excepción a la Regla de Cotización 5250(c)(1) de Nasdaq, que requiere la presentación oportuna de informes financieros periódicos ante la SEC.
La empresa está trabajando con AlixPartners LLP para acelerar el proceso de presentación y planea realizar una llamada de conferencia pública para revisar los resultados financieros una vez que se presente el informe.
Evolv Technology (NASDAQ: EVLV)는 나스닥의 상장 요건 준수를 위한 연장을 받았습니다. 이 연장은 2025년 1월 31일에 부여되었으며, 회사는 2025년 5월 19일까지 Q3 2024 분기 보고서(양식 10-Q)를 제출해야 합니다. 이 연장은 나스닥의 상장 규칙 5250(c)(1)에 대한 예외로 부여된 것으로, 정기 재무 보고서를 SEC에 적시에 제출해야 하는 요구 사항을 포함합니다.
회사는 AlixPartners LLP와 협력하여 제출 프로세스를 가속화하고, 보고서가 제출되면 재무 결과를 검토하기 위한 공개 컨퍼런스 콜을 개최할 계획입니다.
Evolv Technology (NASDAQ: EVLV) a reçu une extension de la Nasdaq concernant sa conformité aux exigences de cotation. L'extension, accordée le 31 janvier 2025, donne à l'entreprise jusqu'au 19 mai 2025 pour déposer son Rapport Trimestriel Q3 2024 (Formulaire 10-Q). L'extension a été accordée en tant qu'exception à la Règle de Cotation 5250(c)(1) de la Nasdaq, qui exige le dépôt en temps voulu des rapports financiers périodiques auprès de la SEC.
L'entreprise collabore avec AlixPartners LLP pour accélérer le processus de dépôt et prévoit d'organiser une conférence téléphonique publique pour revoir les résultats financiers dès que le rapport sera déposé.
Evolv Technology (NASDAQ: EVLV) hat von der Nasdaq eine Verlängerung bezüglich der Einhaltung der Zulassungsanforderungen erhalten. Die Verlängerung, die am 31. Januar 2025 gewährt wurde, gibt dem Unternehmen bis zum 19. Mai 2025 Zeit, um seinen Quartalsbericht Q3 2024 (Formular 10-Q) einzureichen. Die Verlängerung wurde als Ausnahme von der Nasdaq-Zulassungsregel 5250(c)(1) gewährt, die die fristgerechte Einreichung von periodischen Finanzberichten bei der SEC erfordert.
Das Unternehmen arbeitet mit AlixPartners LLP zusammen, um den Einreichungsprozess zu beschleunigen, und plant, eine öffentliche Telefonkonferenz abzuhalten, um die Finanzergebnisse zu überprüfen, sobald der Bericht eingereicht wurde.
- Received extension from Nasdaq to maintain listing compliance
- Engaged AlixPartners LLP to expedite financial reporting
- Delayed filing of Q3 2024 financial reports
- Non-compliance with regular SEC filing requirements
- Risk of potential delisting if deadline not met
Insights
The granting of an extension by Nasdaq for Evolv Technology's Q3 2024 financial report filing warrants serious attention. The nearly eight-month delay from the original due date to the new May 19, 2025 deadline is exceptionally long, raising red flags about potential underlying issues in financial reporting or internal controls.
The engagement of AlixPartners LLP is particularly noteworthy. This firm is typically brought in for complex financial situations, restructuring, or when companies face significant operational or accounting challenges. Their involvement suggests the issues may be more substantial than routine filing delays.
For investors, this situation presents several concerns:
- The extended delay in financial reporting creates significant information asymmetry in the market
- The company's inability to file timely reports may indicate material weaknesses in internal controls
- There's increased risk of potential restatements or accounting adjustments
- The company remains at risk of delisting if it fails to meet the extended deadline
While the extension provides temporary relief from immediate delisting concerns, it's important to note that continued non-compliance could result in more severe consequences. The market typically views such delays negatively, as they create uncertainty and raise questions about operational and financial transparency.
About Evolv Technology
Evolv Technology (NASDAQ: EVLV) is designed to transform human security to make a safer, faster, and better experience for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than two billion people since 2019. Evolv has been awarded the
Forward-looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend for such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including statements regarding the timing of the filing of the Company’s Quarterly Report. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results and actions to be materially different from any future results or actions expressed or implied by the forward-looking statements, including, but not limited to, the factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 29, 2024, as any such factors may be updated from time to time in our other filings with the SEC, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. The forward-looking statements in this press release are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release, whether as a result of any new information, future events or otherwise.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250203635789/en/
Investor Relations:
Brian Norris
Senior Vice President of Finance and Investor Relations
bnorris@evolvtechnology.com
Media Relations:
Alex Ozerkis
Vice President of Corporate Communications
aozerkis@evolvtechnology.com
Source: Evolv Technologies Holdings, Inc.
FAQ
When is Evolv Technology's (EVLV) deadline to file its Q3 2024 quarterly report?
What is the reason for EVLV's Nasdaq listing compliance issue?
Who is helping Evolv Technology (EVLV) with their financial reporting?